☆ 4.6 Meeting Abstract

The PI3K-γ inhibitor, IPI-549, increases antitumor immunity by targeting tumor-associated myeloid cells and remodeling the immune-suppressive tumor microenvironment

CANCER IMMUNOLOGY RESEARCH (2016)

Get Full Text
Add to Collection

Journal

CANCER IMMUNOLOGY RESEARCH
Volume 4, Issue 11, Pages -

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2326-6066.IMM2016-B032

Keywords

-

Categories

Oncology Immunology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.